Brivaracetam 100 mg daily and ethinylestradiol/levonorgestrel combination oral contraceptive - drug interaction potential.

Trial Profile

Brivaracetam 100 mg daily and ethinylestradiol/levonorgestrel combination oral contraceptive - drug interaction potential.

Completed
Phase of Trial: Phase I

Latest Information Update: 08 Apr 2014

At a glance

  • Drugs Brivaracetam (Primary) ; Ethinylestradiol/levonorgestrel (Primary)
  • Indications Epilepsy; Pregnancy
  • Focus Pharmacokinetics
  • Sponsors UCB Pharma AG
  • Most Recent Events

    • 08 Apr 2014 New trial record
    • 11 Feb 2014 Results published in the Epilepsia.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top